This year we have to do more than just rely on the flu vaccine. Avoiding the flu plus COVID-19 catastrophe is contingent on the US widely embracing public health guidance of wearing masks, meticulous hand hygiene and social distancing.
Many are bracing for an unbelievably bad winter with the flu plus COVID-19 teaming up to devastate our population. Whether or not this happens is up to us. Many feel we can blunt this dire warning by encouraging vaccination. However, I would assert that the vaccine this year may be problematic, but we can devastate the flu virus through wearing masks and social distancing. If we do not widely embrace this public health intervention, the flu virus may team up with coronavirus disease 2019 (COVID-19) and devastate us. Here is why.
Kevin Kavanagh, MD
Unlike the United States, many countries in the Southern Hemisphere have embraced the wearing of masks and are taking SARS-CoV-2 very seriously. SARS-CoV-2 is very infectious with an R0 of 5.7. These interventions have certainly blunted this epidemic but in many areas the epidemic still rages. However, these same interventions are effective in preventing the spread of the flu. The flu is much less infective with an R0 of 1.3. In other words, these interventions may slow down, but not stop SARS-CoV-2 but they may well devastate the flu virus. And this is what appears to have happened this spring in the United States and in the Southern Hemisphere.
If one looks at the data from the CDC, the flu became almost nonexistent in the United States by the end of March, with a very steep drop-off in cases.
Centers for Disease Control and Prevention
The World Health Organization (WHO) data from the Southern Hemisphere is even more surprising. Summer is their peak Flu season. But unlike previous years no viral specimens were submitted to the WHO from many countries during the Summer months.
World Health Organization
Last year Chile had 20,949 cases, this year there were only 1134. Claudia Cortés, MD, told the Wall Street Journal: “We were surprised by the decline in the other viruses like influenza. We never dreamed it would practically disappear.”
With both the reduction in international travel and the reduced specimens submitted to the WHO from the Southern Hemisphere, it may be difficult to predict which antigens to incorporate in the United States’ vaccine. Flu vaccines often are not truly effective in stopping the disease, but this year vaccine production may be problematic.
Thus, this year we have to do more than just rely on the flu vaccine. Avoiding the flu plus COVID-19 catastrophe is contingent on the US widely embracing public health guidance of wearing masks, meticulous hand hygiene and social distancing, for which we are a long way from doing. Even some of our elected officials are still downplaying the seriousness of this virus and advocating only those at high risk to wear masks, to protect the wearer. And, of course, we all need the added protection of getting a flu vaccination.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
Breaking the Cycle: Long COVID's Impact and the Urgent Need for Preventative Measures
November 15th 2024Masking, clean air, and vaccinations are essential in combating COVID-19 and preventing long-term impacts, as evidence mounts of long COVID's significant economic, cognitive, and behavioral effects.
Our Understanding of Immune Issues Is Evolving: Here Are 5 Reasons Why
October 25th 2024The past 5 years in medicine have seen significant advances in RNA vaccines, understanding immune dysregulation, and improved interspecialty communication, promising better disease eradication and tailored treatments.